Novartis builds on commitment to addressing need in neuropsychiatric disorders with Cadent Therapeutics acquisition Read more
Moderna Receives FDA Advisory Committee Vote Supporting Emergency Use for Moderna’s Vaccine Against COVID-19 in the United States Read more
Ultragenyx and Mereo BioPharma Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta Read more
FDA approves GSK’s BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US Read more
Conference Chair from Johnson & Johnson invites you to attend Pre-filled Syringes East Coast 2021 Read more
Exclusive Interview: Julian Bahr, Postdoctoral Fellow at AstraZeneca and speaker at 3D Cell Culture Conference Read more
Novartis investigational oral therapy iptacopan (LNP023) receives FDA Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation for C3G Read more
Genosity Enters Into an Agreement With Gemini Therapeutics to Develop a Diagnostic and Implement Testing to Support Gemini’s Age-Related Macular Degeneration Trial Read more
Novartis announces positive FDA Advisory Committee recommendation for use of Entresto to treat patients with HFpEF Read more